Saud Al Babtain Cardiac Center Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2018
NCT04303390
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Saud Al Babtain Cardiac Center | Saud AlBabtain Cardiac Center